MRI Sequences — T1, T2, FLAIR, DWI, SWI, Post-Contrast

This page walks through each routine MRI sequence — what it is sensitive to, classic patterns, and the traps that catch even experienced readers. Pair this with the Physics Primer page for signal-intensity rules; here, the focus is sequence-by-sequence interpretation.

🔹 Bottom Line: Sequence-by-Sequence Workflow

  • T1 — anatomy + atrophy + subacute hemorrhage (bright methemoglobin) + fat + melanin. Best gray-white differentiation.
  • T2 — pathology screen. Water (edema, gliosis, cyst, demyelination, infarct) bright.
  • FLAIR — T2 with CSF suppressed. Workhorse for periventricular, cortical, juxtacortical lesions.
  • DWI + ADC — cytotoxic edema (acute infarct, abscess, lymphoma, prion). Always pair DWI with ADC to avoid T2 shine-through.
  • SWI / GRE — blood, calcium, iron, air, melanin. Detects microbleeds, cavernoma, CVT, CAA.
  • Post-contrast T1 — BBB breakdown OR vascular. Pattern (ring, nodular, gyriform, leptomeningeal, dural) drives differential.
  • MRA / MRV — vessels (separate page on angiography).
  • Optional: post-contrast FLAIR (leptomeningeal), DTI (tractography), perfusion (CTP / DSC / ASL), MR spectroscopy.

T1-Weighted

Use

  • Anatomy + atrophy assessment.
  • Identifies fat, methemoglobin, melanin, mineralization, gyriform cortical laminar necrosis.
  • Post-contrast T1 detects BBB breakdown / vascular structures.

What to Look For

  • Cortical thickness and atrophy patterns — symmetric vs asymmetric, lobar predominance.
  • Hippocampal volume — coronal MTL, especially in dementia and epilepsy workup.
  • Brainstem volume — midbrain atrophy in PSP; pons + middle cerebellar peduncle atrophy in MSA.
  • Bright T1 signal — subacute hemorrhage, melanin (primary melanoma, neurocutaneous melanosis), fat (lipoma, dermoid, marrow), high-protein cysts (colloid, Rathke), manganese (PN, liver failure), gadolinium deposition (dentate, globus pallidus — cumulative dosing).
  • Dark T1 cortical band — laminar necrosis (subacute infarct, hypoxia, status epilepticus).

T2-Weighted

Use

  • Pathology screen — most lesions are bright on T2.
  • Identifies edema, gliosis, cyst, demyelination, tumor, infarct.
  • Detects iron, calcium, fibrous/cellular tissue (dark).

What to Look For

  • White matter T2 hyperintensity — small vessel ischemia, MS, leukodystrophy, CADASIL (anterior temporal + external capsule), Susac (corpus callosum “snowballs”).
  • Deep gray T2 hyperintensity — symmetric: metabolic / toxic / mitochondrial / Wernicke / hypoxic; asymmetric: stroke, encephalitis.
  • Cortical T2 hyperintensity — subacute infarct, encephalitis (HSV → medial temporal), autoimmune (limbic), CJD ribbon, status epilepticus.
  • Brainstem T2 hyperintensity — pontine perforator infarcts (lacunar pattern), MS, central pontine myelinolysis, NMO, mitochondrial.
  • Iron-related T2 darkening — globus pallidus (normal aging, NBIA), substantia nigra (loss of swallow-tail in PD), dentate (CTX), red nucleus.

FLAIR

Use

  • T2 with CSF nulled. Sensitive to lesions next to CSF spaces — periventricular and juxtacortical.
  • The single most useful sequence for MS, gliosis, low-grade tumor, encephalitis.

Patterns

  • Periventricular FLAIR hyperintensity — MS plaques (perpendicular Dawson fingers), small vessel ischemia (more confluent), transependymal CSF flow (smooth halo), CADASIL.
  • Juxtacortical FLAIR hyperintensity — MS (especially U-fibers), encephalitis, FCD type IIB (transmantle sign), low-grade glioma.
  • Cortical FLAIR hyperintensity — subacute stroke, encephalitis, CJD ribbon, status epilepticus, MELAS stroke-like episode.
  • Bilateral mesial temporal FLAIR hyperintensity — herpes encephalitis (asymmetric typically), autoimmune limbic encephalitis (anti-LGI1, anti-CASPR2, anti-Hu), seizure-related, hypoglycemia.
  • Sulcal FLAIR hyperintensity — leptomeningeal disease (carcinomatous, infectious meningitis), SAH (hyperacute), hyperoxygenation under anesthesia, propofol, gadolinium leakage in renal failure.
  • Splenium of corpus callosum FLAIR hyperintensity — MERS (mild encephalopathy with reversible splenial lesion), CADASIL, AED toxicity, status, MS, ischemia.

FLAIR Pitfalls

  • CSF flow artifact in posterior fossa (4th ventricle) — false bright.
  • Hyperoxygenation (general anesthesia, high FiO2) → diffuse sulcal FLAIR bright.
  • Propofol → sulcal FLAIR brightness.
  • Gadolinium leakage into CSF in renal failure or BBB-disrupted states.

DWI / ADC

Use

  • Detects water motion restriction.
  • True restriction = bright on DWI AND dark on ADC.
  • Single most useful sequence for acute ischemic stroke (positive within minutes).

Causes of True Restriction

  • Acute ischemic stroke — within minutes; “DWI-positive but FLAIR-negative” identifies treatable window.
  • Abscess — central pus restricts; helps distinguish from ring-enhancing tumor.
  • Hypercellular tumors — lymphoma, medulloblastoma, glioblastoma (focal areas).
  • Prion disease — cortical ribbon + basal ganglia + pulvinar pattern.
  • Acute MS / NMO plaque center — transient restriction.
  • Herpes encephalitis — medial temporal.
  • Wernicke encephalopathy — mammillary bodies, periaqueductal, dorsomedial thalamus.
  • Status epilepticus — peri-ictal cortical + ipsilateral thalamus.
  • Hypoglycemia — cortical (especially parieto-occipital), hippocampal, splenium.
  • Epidermoid cyst — viscous fluid (distinguishes from arachnoid cyst).
  • Cytotoxic lesion of corpus callosum — splenium central restriction (MERS, drug-related).
  • PRES variant with infarction — late-stage cytotoxic injury.

DWI Traps

  • T2 shine-through: high DWI without ADC darkness ≠ restriction. Always confirm ADC.
  • T2 black-out: very dark T2 lesions (chronic blood, calcium) can appear “restricted” via inverse artifact. Correlate with SWI/T2*.
  • Susceptibility artifact at skull base + posterior fossa (sinus air, dental hardware) obscures DWI — be cautious calling restriction here.

SWI / GRE / T2*

Use

  • Susceptibility-weighted; sensitive to anything that distorts the local magnetic field.
  • Detects blood, calcium, iron, air, melanin.
  • SWI > GRE > T2* in sensitivity.

Key Findings

  • Microbleeds — small (<10 mm), round, blooming hypointensities. Patterns:
    • Lobar (cortical / subcortical) → cerebral amyloid angiopathy (CAA).
    • Deep (basal ganglia, thalamus, pons, cerebellum) → hypertensive vasculopathy.
    • Diffuse small + skull base → diffuse axonal injury.
    • Mixed deep + lobar → mixed CAA / hypertensive.
  • Cerebral amyloid angiopathy (modified Boston criteria) — multiple lobar microbleeds + cortical superficial siderosis ± lobar ICH in elderly. SWI is critical.
  • Cavernous malformation — “popcorn” mixed-signal core + complete dark hemosiderin rim. Often multifocal in familial forms.
  • Cerebral venous sinus thrombosis — low signal in occluded sinus + blooming around. Cortical vein thrombosis shows linear dark signal in superficial cortex with adjacent edema.
  • Hemorrhagic transformation of infarct — petechial → confluent hyperdensity / blooming.
  • Substantia nigra “swallow-tail sign” — normally bright dorsolateral SN compartment; loss = PD or atypical parkinsonism.
  • MS — central vein sign — small vein passing through plaque (high specificity for MS vs ischemic white matter disease).
  • Calcification — common in normal globus pallidus, choroid plexus, pineal, falx; pathologic in oligodendroglioma, meningioma, Fahr, hypoparathyroidism.

Post-Contrast T1

Use

  • Detects BBB breakdown (tumors, abscess, inflammation, demyelination, metastasis).
  • Highlights normal vascular structures (vessels, sinuses, choroid, pituitary stalk).

Patterns and Differential

Pattern Common Differential
Solid / nodular Metastasis, lymphoma, meningioma, schwannoma, hemangioblastoma
Ring Glioblastoma, metastasis, abscess (DWI + ADC distinguishes), tumefactive demyelination (open ring), radiation necrosis, lymphoma (often solid), resolving hematoma
Open ring (incomplete on cortical / venous side) Tumefactive demyelinating plaque (MS)
Gyriform cortical Subacute infarct (laminar necrosis, 1–2 weeks), encephalitis (HSV, autoimmune), status epilepticus, MELAS stroke-like episode
Leptomeningeal (sulcal / pial) Carcinomatous meningitis (lymphoma, breast, lung, melanoma), infectious meningitis (TB, fungal, bacterial), neurosarcoidosis, IgG4 disease
Dural (smooth, diffuse, linear) Intracranial hypotension, postoperative, meningioma (en plaque)
Dural (nodular, focal) Meningioma, dural metastasis, neurosarcoidosis, lymphoma, Erdheim-Chester
Ependymal Ependymitis (CMV in HIV/transplant), lymphoma, glioblastoma seeding, neurocysticercosis
Perivascular (Virchow-Robin) enhancement Neurosarcoidosis, CNS vasculitis, lymphoma
Cranial nerve enhancement Schwannoma, perineural tumor spread (head/neck cancer), neurosarcoidosis, Bell palsy (CN VII), GBS / CIDP (cauda)
Pituitary / sellar enhancement Adenoma (often hypo-enhancing relative to gland), hypophysitis (homogeneous + thickened stalk), Rathke cleft, craniopharyngioma
Punctate “starry sky” Miliary TB, miliary metastases, neurocysticercosis

Post-Contrast FLAIR

  • Most sensitive sequence for leptomeningeal disease — combines T2 / FLAIR contrast with gadolinium enhancement of pial vessels.
  • Sensitive for early infarct cortical enhancement, low-volume hydrocephalus, low-volume SAH.
  • Order when carcinomatous or infectious meningitis is suspected.

Specialty Sequences (Briefly)

  • DTI / tractography: white matter tract integrity (presurgical planning, TBI, MS, leukodystrophy research).
  • MR spectroscopy: metabolic profile of a voxel (NAA, choline, creatine, lipid, lactate). Useful for tumor grade, radiation necrosis vs recurrence, mitochondrial disease, NAA deficits in white matter disease.
  • Functional MRI (fMRI): BOLD signal mapping for language, motor, memory; presurgical planning.
  • MR perfusion (DSC, ASL): see Perfusion page.
  • SVS spectroscopy mnemonic: NAA down (neuronal loss), choline up (cell turnover), lactate up (anaerobic), lipid up (necrosis).
  • Time-of-flight MRA / MRV: see Angiography page.

🔹 Clinical Relevance: Building the MRI Around the Question

The right MRI protocol depends on what you’re asking:

  • Acute stroke: T2, FLAIR, DWI/ADC, SWI, MRA head + neck.
  • MS / demyelinating: 3D-FLAIR, T1 pre + post, T2, DWI, SWI (central vein sign), sagittal cord T2 + STIR.
  • Tumor: T1 pre + post, T2, FLAIR, DWI/ADC, SWI, perfusion (DSC), spectroscopy.
  • Epilepsy presurgical: high-resolution 3T, dedicated epilepsy protocol (T2, FLAIR, MPRAGE, DTI), thin-slice coronal hippocampal.
  • Dementia: T1 MPRAGE volumetric, T2, FLAIR, SWI (microbleeds, CAA), targeted PET as next step.
  • Encephalitis: T2, FLAIR, DWI, post-contrast T1 + post-contrast FLAIR.
  • Pituitary / sellar: dynamic post-contrast T1 + sagittal + coronal thin cuts of sella.
  • CSF leak / intracranial hypotension: post-contrast T1 + heavily T2-weighted MR myelography.
  • NPH: T1 volumetric for DESH pattern + Evans index + callosal angle.

Pitfalls and Pearls

  • Always pair DWI with ADC — T2 shine-through is the universal trap.
  • Open-ring enhancement = tumefactive demyelination, not abscess or tumor.
  • Central vein sign on SWI = high specificity for MS over ischemic white matter lesions.
  • Mesial temporal asymmetry on FLAIR + DWI = think HSV (asymmetric, hemorrhagic, often unilateral); autoimmune limbic encephalitis (more bilateral, less aggressive); seizure-related (correlate with EEG).
  • Cortical ribbon DWI + pulvinar FLAIR = CJD.
  • Pulvinar T2 bright bilaterally = consider variant CJD, Fabry, hypoglycemic injury, mitochondrial.
  • Splenium central focal lesion with restriction = MERS, AED-related, ischemic, MS.
  • Bilateral basal ganglia symmetric T2 bright = metabolic (hypoxia, CO, methanol), Wernicke, mitochondrial (Leigh), Wilson, NPC, manganese.
  • Loss of swallow-tail sign on SWI = Parkinson disease (dopaminergic SN loss).
  • Smooth dural enhancement + brain sagging = intracranial hypotension; look for CSF leak.
  • Gadolinium leakage into CSF in renal failure can mimic SAH on FLAIR — clinical correlation.
  • Don’t read “brain MRI” without checking the cord — sagittal T1/T2 visible through cervicomedullary level.

References

  1. Filippi M, Preziosa P, Banwell BL, et al. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines. Brain. 2019;142(7):1858-1875.
  2. Osborn AG. Osborn’s Brain. 2nd ed. Elsevier; 2018.
  3. Provenzale JM. The role of advanced MR techniques in the diagnosis of brain tumors. Magn Reson Imaging Clin N Am. 2007;15(2):283-298.
  4. Vernooij MW, van der Lugt A, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology. 2008;70(14):1208-1214.